Revolution Medicines Q1 Net Loss Narrows
Revolution Medicines (RVMD) reported a Q1 net loss Wednesday of $0.70 per share, narrowing from a loss of $0.72 a year earlier. Analysts polled by Capital IQ expected a loss of $0.75. The company did
Revolution Medicines Reiterates Projected Full Year 2024 GAAP Net Loss To Be $(480)M-$(520)M
Based on the company's current operating plan, the company projects current cash, cash equivalents and marketable securities can fund planned operations into 2027.
10-Q: Quarterly report
Press Release: Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., May 08,
Revolution Medicines 1Q Loss/Shr 70c >RVMD
Revolution Medicines 1Q Loss/Shr 70c >RVMD
Insider Sale: CFO Jack Anders Sells 10,000 Shares of Revolution Medicines Inc (RVMD)
Revolution Medicines(RVMD.US) Officer Sells US$400.26K in Common Stock
$Revolution Medicines(RVMD.US)$ Officer Anders Jack sold 10,000 shares of common stock on May 3, 2024 at an average price of $40.026 for a total value of $400.26K.Source: Announcement What is statemen
S&P 500 Futures Decline In Premarket Trading; Paramount Global, Revolution Medicines Lead
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Paramount Global Cl B (PARA) was up 9.6% in pre-mar
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Revolution Medicines (RVMD)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intuitive Surgical (ISRG) and Revolution Medicines (RVMD) with bullish sentiments.
Revolution Medicines(RVMD.US) Officer Sells US$619.47K in Common Stock
$Revolution Medicines(RVMD.US)$ Officer GOLDSMITH MARK A sold 17,500 shares of common stock on Apr 10, 2024 at an average price of $35.3981 for a total value of $619.47K.Source: Announcement What is s
Revolution Medicines(RVMD.US) Director Sells US$79,735 in Common Stock
$Revolution Medicines(RVMD.US)$ Director Patel Sushil sold 2,155 shares of common stock on Apr 10, 2024 at an average price of $37 for a total value of $79,735.Source: Announcement What is statement o
Top 10 Stocks With Upwards and Downwards Daily Percentage Change - Piper Sandler
Top 3 Health Care Stocks That May Collapse In Q2
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indica
Revolution Medicines Price Target Raised to $45.00/Share From $43.00 by Oppenheimer
Revolution Medicines Price Target Raised to $45.00/Share From $43.00 by Oppenheimer
Oppenheimer Sticks to Their Buy Rating for Revolution Medicines (RVMD)
Revolution Medicines Receives Buy Rating Amid Promising Cancer Treatment Data and Expanded Market Opportunities
Revolution Medicines Is Maintained at Buy by Needham
Revolution Medicines Is Maintained at Buy by Needham
Needham: Maintaining the Revolution Medicines (RVMD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $36.00 to $46.00.
Needham: Maintaining the Revolution Medicines (RVMD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $36.00 to $46.00.
Needham Maintains Buy on Revolution Medicines, Raises Price Target to $46
Needham analyst Ami Fadia maintains Revolution Medicines with a Buy and raises the price target from $36 to $46.
Form 144 | Revolution Medicines(RVMD.US) Director Proposes to Sell 164.95K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 10, $Revolution Medicines(RVMD.US)$、$REVOLUTION MEDICINES INC C/WTS (TO PUR COM)(RVMDW.US)$ Director REBECCA EVE GOLDSMITH TRU/A DTD 12/15/2011 intends to sell 5,000 shares
No Data